help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamegai, J.
Right arrow Articles by Kineman, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamegai, J.
Right arrow Articles by Kineman, R. D.
Endocrinology Vol. 139, No. 8 3554-3560
Copyright © 1998 by The Endocrine Society

ARTICLES

Hypothalamic/Pituitary-Axis of the Spontaneous Dwarf Rat: Autofeedback Regulation of Growth Hormone (GH) Includes Suppression of GH Releasing-Hormone Receptor Messenger Ribonucleic Acid1

Jun Kamegai2, Terry G. Unterman, Lawrence A. Frohman and Rhonda D. Kineman

Section of Endocrinology and Metabolism, Department of Medicine, University of Illinois at Chicago (J.K., T.G.U., L.A.F, R.D.K.); and Department of Medicine, Chicago Veterans Administration Health Care System, West Side Division (T.G.U.), Chicago, Illinois 60612

Address all correspondence and requests for reprints to: R. D. Kineman, Section of Endocrinology and Metabolism, Department of Medicine, University of Illinois at Chicago, 1819 West Polk, M/C 640, Chicago, Illinois 60612. E-mail: kineman{at}uic.edu

In this study, the spontaneous dwarf rat (SDR) has been used to examine GHRH production and action in the selective absence of endogenous GH. This dwarf model is unique in that GH is not produced because of a point mutation in the GH gene. However, other pituitary hormones are not obviously compromised. Examination of the hypothalamic pituitary-axis of SDRs revealed that GHRH messenger RNA (mRNA) levels were increased, whereas somatostatin (SS) and neuropeptide Y (NPY) mRNA levels were decreased, compared with age- and sex-matched normal controls, as determined by Northern blot analysis (n = 5 animals/group; P < 0.05). The elevated levels of GHRH mRNA in the SDR hypothalamus were accompanied by a 56% increase in pituitary GHRH receptor (GHRH-R) mRNA, as determined by RT-PCR (P < 0.05). To investigate whether the up-regulation of GHRH-R mRNA resulted in an increase in GHRH-R function, SDR and control pituitary cell cultures were challenged with GHRH (0.001–10 nM; 15 min), and intracellular cAMP concentrations were measured by RIA. Interestingly, SDR pituitary cells were hyperresponsive to 1 and 10 nM GHRH, which induced a rise in intracellular cAMP concentrations 50% greater than that observed in control cultures (n = 3 separate experiments; P < 0.05 and P < 0.01, respectively). Replacement of GH, by osmotic minipump (10 µg/h for 72 h), resulted in the suppression of GHRH mRNA levels (P < 0.01), whereas SS and NPY mRNA levels were increased (P < 0.05), compared with vehicle-treated controls (n = 5 animals/treatment group). Consonant with the fall in hypothalamic GHRH mRNA was a decrease in pituitary GHRH-R mRNA levels. Although replacement of insulin-like growth factor-I (IGF-I), by osmotic pump (5 µg/h for 72 h), resulted in a rise in circulating IGF-I concentrations comparable with that observed after GH replacement, IGF-I treatment was ineffective in modulating GHRH, SS, or NPY mRNA levels. However, IGF-I treatment did reduce pituitary GHRH-R mRNA levels, compared with vehicle-treated controls (P < 0.05). These results further validate the role of GH as a negative regulator of hypothalamic GHRH expression, and they suggest that SS and NPY act as intermediaries in GH-induced suppression of hypothalamic GHRH synthesis. These data also demonstrate that increases in circulating IGF-I are not responsible for changes in hypothalamic function observed after GH treatment. Finally, this report establishes modulation of GHRH-R synthesis as a component of GH autofeedback regulation.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
I. Garcia-Tornadu, M. Rubinstein, B. D Gaylinn, D. Hill, E. Arany, M. J Low, G. Diaz-Torga, and D. Becu-Villalobos
GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
J. Endocrinol., September 1, 2006; 190(3): 611 - 619.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
E Kim, S Sohn, M Lee, J Jung, R D Kineman, and S Park
Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes
J. Endocrinol., February 1, 2006; 188(2): 263 - 270.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Alba, A. V. Schally, and R. Salvatori
Partial Reversibility of Growth Hormone (GH) Deficiency in the GH-Releasing Hormone (GHRH) Knockout Mouse by Postnatal Treatment with a GHRH Analog
Endocrinology, March 1, 2005; 146(3): 1506 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, A. Tatsuguchi, H. Sugihara, S. Oikawa, and R. D. Kineman
The Role of Pituitary Ghrelin in Growth Hormone (GH) Secretion: GH-Releasing Hormone-Dependent Regulation of Pituitary Ghrelin Gene Expression and Peptide Content
Endocrinology, August 1, 2004; 145(8): 3731 - 3738.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. M. Luque, R. D. Kineman, S. Park, X.-D. Peng, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon
Homologous and Heterologous Regulation of Pituitary Receptors for Ghrelin and Growth Hormone-Releasing Hormone
Endocrinology, July 1, 2004; 145(7): 3182 - 3189.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Lall, N. Balthasar, D. Carmignac, C. Magoulas, A. Sesay, P. Houston, K. Mathers, and I. Robinson
Physiological Studies of Transgenic Mice Overexpressing Growth Hormone (GH) Secretagogue Receptor 1A in GH-Releasing Hormone Neurons
Endocrinology, April 1, 2004; 145(4): 1602 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. E. Caminos, R. Nogueiras, M. Blanco, L. M. Seoane, S. Bravo, C. V. Alvarez, T. Garcia-Caballero, F. F. Casanueva, and C. Dieguez
Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland
Endocrinology, November 1, 2003; 144(11): 5089 - 5097.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. L. Hurley, D. V. Birch, M. C. Almond, I. J. Estrada, and C. J. Phelps
Reduced Hypothalamic Neuropeptide Y Expression in Growth Hormone- and Prolactin-Deficient Ames and Snell Dwarf Mice
Endocrinology, November 1, 2003; 144(11): 4783 - 4789.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Liu, L. Robillard, B. Banihashemi, and P. R. Albert
Growth Hormone-induced Diacylglycerol and Ceramide Formation via Galpha i3 and Gbeta gamma in GH4 Pituitary Cells. POTENTIATION BY DOPAMINE-D2 RECEPTOR ACTIVATION
J. Biol. Chem., December 6, 2002; 277(50): 48427 - 48433.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. M. Swanson and T. G. Unterman
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis
Carcinogenesis, June 1, 2002; 23(6): 977 - 982.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Wallenius, K. Sjogren, X.-D. Peng, S. Park, V. Wallenius, J.-L. Liu, M. Umaerus, H. Wennbo, O. Isaksson, L. Frohman, et al.
Liver-Derived IGF-I Regulates GH Secretion at the Pituitary Level in Mice
Endocrinology, November 1, 2001; 142(11): 4762 - 4770.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman
The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling
Endocrinology, September 1, 2001; 142(9): 3764 - 3773.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
F. Obal Jr, J. Fang, P. Taishi, B. Kacsoh, J. Gardi, and J. M. Krueger
Deficiency of Growth Hormone-Releasing Hormone Signaling Is Associated with Sleep Alterations in the Dwarf Rat
J. Neurosci., April 15, 2001; 21(8): 2912 - 2918.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X.-d. Peng, S. Park, M. R. Gadelha, K. T. Coschigano, J. J. Kopchick, L. A. Frohman, and R. D. Kineman
The Growth Hormone (GH)-Axis of GH Receptor/Binding Protein Gene-Disrupted and Metallothionein-Human GH-Releasing Hormone Transgenic Mice: Hypothalamic Neuropeptide and Pituitary Receptor Expression in the Absence and Presence of GH Feedback
Endocrinology, March 1, 2001; 142(3): 1117 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Park, J. Kamegai, T. A. Johnson, L. A. Frohman, and R. D. Kineman
Modulation of Pituitary Somatostatin Receptor Subtype (sst1-5) Messenger Ribonucleic Acid Levels by Changes in the Growth Hormone Axis
Endocrinology, October 1, 2000; 141(10): 3556 - 3563.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. D. Kineman, J. Kamegai, and L. A. Frohman
Growth Hormone (GH)-Releasing Hormone (GHRH) and the GH Secretagogue (GHS), L692,585, Differentially Modulate Rat Pituitary GHS Receptor and GHRH Receptor Messenger Ribonucleic Acid Levels
Endocrinology, August 1, 1999; 140(8): 3581 - 3586.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society